News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Alnylam Pharmaceuticals
NEWS
JOBS
IN THE PRESS
NEWS
Drug Development
Cream ‘Could Stop Genital Herpes’, Harvard Medical School Study
January 22, 2009
·
1 min read
Drug Development
Alnylam Pharmaceuticals: RNA Interference Holds Promise For Cholesterol-Lowering Drugs
November 11, 2008
·
1 min read
New Pathway For Malaria Infection Discovered by Cenix BioScience GmbH, Alnylam Pharmaceuticals and Instituto de Medicina Molecular Researchers
September 15, 2008
·
1 min read
Biotech Bay
Biotech Blossoms Anew
April 29, 2008
·
2 min read
Business
Shanghai GenePharma Licenses Alnylam Pharmaceuticals siRNA Patents
March 24, 2008
·
1 min read
Biotech Bay
Market Highlights: Summer Doldrums Interrupted by RNAi Investment Frenzy
August 1, 2007
·
1 min read
Biotech Beach
The Day In Review: Genentech, Inc. Adds To Pipeline, Again
January 9, 2007
·
1 min read
Biotech Bay
The Day In Review: Cephalon, Inc. Wins Second Indication For Fento
October 11, 2006
·
1 min read
The Day In Review: News On Multiple Sclerosis Drugs
September 28, 2006
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Alnylam to Host Tenth “RNAi Roundtable” Webcast Series
June 12, 2026
·
4 min read
Press Releases
GENESIS Pharma Expands Strategic Commercial Partnership with Alnylam Pharmaceuticals for RNAi Therapeutics to the Nordic Region
June 10, 2026
·
3 min read
Press Releases
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics
June 4, 2026
·
7 min read
Press Releases
Alnylam Issues 2025 Corporate Responsibility Report
May 19, 2026
·
4 min read
Press Releases
New Data Analyses Presented at Heart Failure 2026 Demonstrate Robust and Consistent Clinical Benefit of Vutrisiran as a First-Line Treatment Option Across ATTR-CM Patient Populations, Including Patients with a High Disease Burden
May 12, 2026
·
10 min read
Press Releases
Alnylam to Webcast Presentations at Upcoming Investor Conferences - May 7, 2026
May 7, 2026
·
1 min read
Press Releases
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM
May 4, 2026
·
9 min read
Press Releases
Alnylam Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Period Progress
April 30, 2026
·
19 min read
Press Releases
Tenaya Therapeutics Announces Late-Breaking Oral Presentation of New Clinical Data from RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy in Adults with PKP2-Associated ARVC at ASGCT 2026
April 27, 2026
·
9 min read
Press Releases
Alnylam to Webcast Conference Call Discussing First Quarter 2026 Financial Results
April 17, 2026
·
1 min read
